NASDAQ:OKUR | Income Statement | OnKure Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$12.61M$16.9M-$16.9M-$15.35M-$0.31-$0.3149,869,17749,869,177
2026-03-31$11.71M$15.62M-$15.62M-$15.16M-$1.11-$1.1113,674,57713,674,577
2025-12-31$10.72M$14.13M-$14.13M-$13.5M-$0.99-$0.9927,42227,422
2025-09-30$11.92M$15.5M-$15.5M-$14.7M-$1.09-$1.0913,530,89213,530,892
2025-06-30$12.61M$16.32M-$16.32M-$15.39M-$1.14-$1.1413,509,08013,509,080
2025-03-31$13.01M$17M-$17M-$15.93M-$1.19-$1.1913,424,33513,424,335
2024-12-31$14.36M$18.7M-$18.7M-$17.44M$96.49$96.493,131,8563,131,856
2024-09-30$10.12M$11.51M-$11.51M-$11.56M-$36.55-$36.55316,142316,142
2024-06-30$10.75M$14.34M-$14.34M-$14.14M-$44.82-$44.82315,478315,478
2024-03-31$8.57M$9.83M-$9.83M-$9.54M-$30.37-$30.37314,016314,016
2023-12-31-$6.89M-$21.11M$21.11M$18.52M-$106.30-$106.30-2,688,051-2,688,051
2023-09-30$13.62M$20.89M-$20.89M-$19.2M-$5.68-$5.683,380,7943,380,794
2023-06-30$14.4M$21.04M-$21.04M-$19.53M-$0.65-$0.6530,215,32130,215,321
2023-03-31$10.99M$16.12M-$16.12M-$15.11M-$0.60-$0.6025,036,41025,036,410
2022-12-31$10.36M$14.56M-$14.56M-$13.6M-$0.55-$0.5523,45123,451
2022-09-30$9.94M$13.84M-$13.84M-$13.01M-$0.53-$0.5324,496,31324,496,313
2022-06-30$8.13M$12.43M-$12.43M-$12.31M-$0.50-$0.5024,463,82424,463,824
2022-03-31$9.28M$13.02M-$13.02M-$13.04M-$0.53-$0.5324,458,29024,458,290
2021-12-31$7.1M$10.62M-$10.62M-$10.61M-$0.37-$0.372,117,6742,117,674
2021-09-30$9.32M$12.75M-$12.75M-$12.74M-$0.52-$0.5224,396,79824,396,798
2021-06-30$6.28M$9.23M-$9.23M-$9.22M-$0.43-$0.4321,364,36921,364,369
2021-03-31$5.47M$7.21M-$7.21M-$7.21M-$3.48-$3.482,070,9352,070,935
2020-12-31$5.12M$6.25M-$6.25M-$6.25M7,167
2020-09-30$4.43M$5.1M-$5.1M-$5.09M2,052,838
2020-06-30$2.82M$3.7M-$3.7M-$3.69M2,022,174
2020-03-31$3.58M$4.5M-$4.5M-$4.43M2,015,029

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$48.26M$62.95M-$62.95M$0.00-$59.52M-$4.40-$4.4013,515,91513,515,915
2024-12-31$0.00$43.8M$54.39M-$54.39M$0.00-$52.67M-$15.28-$15.283,447,0713,447,071
2023-12-31$32.12M$36.93M-$36.93M-$77.39M$0.00-$35.31M-$124.41-$124.41283,817283,817
2022-12-31$37.71M$53.85M-$53.85M-$51.96M$0.00-$51.96M-$2.12-$2.1224,496,42524,496,425
2021-12-31$28.17M$39.82M-$39.82M-$39.77M$0.00-$39.77M-$2.19-$2.1918,143,48718,143,487
2020-12-31$15.94M$19.55M-$19.55M-$19.47M$0.00-$19.47M-$9.60-$9.602,028,1982,028,198